독서리서치레이더투자 프레임워크
로그인 / 회원가입
← 읽기로 돌아가기
뉴스주제 · Treat AI医疗融资간단한 요점1 분 소요DisconfirmAI 편집부

Ex-Swappie CEO's AI Health Startup Treat Raises €3M Pre-Seed

Helsinki-based AI healthtech startup Treat closed a €3 million pre-seed round led by byFounders and Illusian to tackle diagnostic inefficiencies.

2026-11-17 14:00 GMT+8

Treat, an AI-focused healthtech company based in Helsinki, has raised €3 million in a pre-seed funding round led by byFounders and Illusian. Illusian is the investment vehicle of Supercell co-founder Ilkka Paananen.

The Finnish startup was founded in 2026 by Sami Marttinen, former CEO of Swappie, along with medical doctor Antti Mauno and fintech engineering lead Onni Wahlberg. The platform uses AI to gather patient symptoms and check insurance coverage, connecting patients to licensed doctors within minutes once their medical history has been reviewed.

Marttinen cited his wife's experience of nine private doctor visits before receiving a diagnosis as the inspiration. He argues that the current economic model rewards repeat visits rather than efficient resolution. Treat claims that 83% of cases are resolved on the first visit and states that no patient records are shared with public LLMs.

The funding round closed just one week after the first conversation. The capital will primarily go toward product development and expansion. Treat currently has over 20 pilot employer customers and expects to be active in more than five countries by the end of the year.

출처

  • techfundingnews.comTech Funding News
로그인 / 회원가입
독서리서치레이더투자 프레임워크
↗
주제

Treat AI医疗融资

芬兰赫尔辛基医疗科技公司Treat于2026年11月宣布完成300万欧元种子前融资,由byFounders和Supercell创始人Ilkka Paananen旗下的Illusian共同领投。该公司由前Swappie CEO Sami Ma…

3 단계1 건업데이트됨 2026-11-19 21:34

현재까지의 과정

  1. 2026-11-16Tech.eu等媒体首次报道Treat完成300万欧元种子前融资,确认投资方为byFounders和Illusian。tech.eu ↗
  2. 2026-11-17EU-Startups详细披露产品机制:AI仅负责信息采集与简报生成,所有临床决策由注册医师做出;公布62%首诊解决率及10.8万累计问诊数据。eu-startups.com ↗
  3. 2026-11-17Sesamers分析指出CEO Marttinen计划年底将业务扩展至5个以上国家,并强调其收入模式与传统按次收费诊所的根本差异。sesamers.com ↗

아직 해결되지 않은 문제

  • Treat承诺的“年底前进入5个以上国家”是否已实现?具体涉及哪些司法辖区及其对应的医疗监管牌照获取情况如何?
  • 随着用户规模扩大,62%的首诊解决率是否能维持?是否有第三方审计或更长期的公开数据支持这一指标?
  • 欧盟《人工智能法案》或其他成员国法规对“AI辅助分诊”的具体合规要求是否会迫使Treat调整其技术架构或业务流程?
전체 주제 읽기 →
리서치 계속하기 →